首页> 外国专利> ANTIBODIES DIRECTED TO ANGIOPOIETIN-LIKE PROTEIN 4 AND USES THEREOF

ANTIBODIES DIRECTED TO ANGIOPOIETIN-LIKE PROTEIN 4 AND USES THEREOF

机译:直接作用于血管生成素样蛋白4的抗体及其用途

摘要

Antibodies directed to the antigen ANGPTL4 and uses of such antibodies. In accordance with the teachings herein, there are provided fully human monoclonal antibodies directed to the antigen ANGPTL4. Nucleotide sequences encoding, and amino acid sequences comprising, heavy and light chain immunoglobulin molecules, particularly sequences corresponding to contiguous heavy and light chain sequences spanning the framework regions and/or complementarity determining regions (CDR's), specifically from FR1 through FR4 or CDR1 through CDR3, are provided. Hybridomas or other cell lines expressing such immunoglobulin molecules and monoclonal antibodies are also provided.
机译:针对抗原ANGPTL4的抗体及其用途。根据本文的教导,提供了针对抗原ANGPTL4的完全人单克隆抗体。编码重链和轻链免疫球蛋白分子的核苷酸序列,以及包含其的氨基酸序列,特别是对应于跨越构架区和/或互补决定区(CDR)的连续重链和轻链序列的序列,特别是从FR1至FR4或CDR1至CDR3提供。还提供了表达此类免疫球蛋白分子和单克隆抗体的杂交瘤或其他细胞系。

著录项

  • 公开/公告号EP2007899B1

    专利类型

  • 公开/公告日2017-06-07

    原文格式PDF

  • 申请/专利权人 CELLDEX THERAPEUTICS INC.;AMGEN FREMONT INC.;

    申请/专利号EP20070753609

  • 发明设计人 ZHONG HAIHONG;ZHOU QING;

    申请日2007-03-20

  • 分类号C07K16/30;C07K16/22;A61K39;A61K47/68;A61K51/10;G01N33/574;

  • 国家 EP

  • 入库时间 2022-08-21 14:06:35

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号